InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the complete record of transactions filed by Culwell Kelly, Directeur Médical. Director active across 2 companies, notably Evofem Biosciences, Inc.. Cumulatively, 1 disclosures have been recorded. Activity tracked since 20 May 2021. The latest transaction was filed on 20 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Culwell Kelly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
42,061 shares@ US$0.86100.0% of flowCommon StockSEC:0001618835-21-000135:0
1 of 1 declaration
About Culwell Kelly
Kelly Culwell is the Chief Medical Officer at Evofem Biosciences, Inc. She is responsible for leading the company's medical initiatives and research and development strategy. Her role includes overseeing clinical trials and ensuring that products meet safety and efficacy standards. She plays a key role in innovation and the development of new treatments.
